B

BioStratum Incorporated

10 employees

BioStratum develops and commercializes therapeutic agents for the treatment of diabetes and diabetic complications.

Investor insights

Sectors invested in

Biotechnology1
Diabetes1
Health Care1

Funding rounds participated in

$3.3M sweet spot round size

Most of their 1 investments are in rounds between $3.3M and $3.3M

Basic info

Industry

accounting

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

1994

Investments made

N

NephroGenex raised $3.3M on July 6, 2007

Investors: BioStratum Incorporated

Funding rounds raised

Total raised

$9.5M

from 2 investors over 2 rounds

B

BioStratum Incorporated raised $9.5M on August 22, 2003

Investors: BankInvest and HealthCap

FAQ